The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines ...

Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...

Shi Zhengli, a leading virologist, became known as “Bat Woman” for her work on coronaviruses. She has spent decades studying ...

But that was one of the first big surprises from the virus dubbed SARS-CoV-2. It evolved like crazy. "SARS-CoV-2 so far has ...

The National Wastewater Surveillance System’s funding expires at the end of fiscal year 2025, just as bird flu heats up.

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

Scientists reveal that reactivation of Epstein-Barr virus (EBV), driven by TGFβ-induced immune suppression, is a key driver ...

New findings add weight to the theory that COVID-19 originated at the Wuhan Institute of Virology. Experts point to lax ...

A slow immune response to SARS-CoV-2 infection, delayed viral clearance, and viral rebound can all increase a person’s risk ...

Even as the news of a woman in Kolkata being infected with Human Coronavirus HKU1 has raised fresh concerns, health experts ...

HKU1 infection typically presents as an upper respiratory tract illness with symptoms like cough, cold, sneezing, and throat ...

Betacoronavirus hongkonense, commonly known as human coronavirus HKU1 (HCoV-HKU1), is a species of coronavirus that affects ...